UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000049055
Receipt number R000055892
Scientific Title Evaluation of the Efficacy and Safety of a Stand-Assisted Electric Wheelchair in Patients with Muscular Dystrophy
Date of disclosure of the study information 2022/10/01
Last modified on 2023/10/01 15:26:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of the Efficacy and Safety of a Stand-Assisted Electric Wheelchair in Patients with Muscular Dystrophy

Acronym

Evaluation of the Efficacy and Safety of a Stand-Assisted Electric Wheelchair in Patients with Muscular Dystrophy

Scientific Title

Evaluation of the Efficacy and Safety of a Stand-Assisted Electric Wheelchair in Patients with Muscular Dystrophy

Scientific Title:Acronym

Evaluation of the Efficacy and Safety of a Stand-Assisted Electric Wheelchair in Patients with Muscular Dystrophy

Region

Japan


Condition

Condition

Muscular dystrophy

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Investigation of the effectiveness and safety of a stand-supported electric wheelchair and its effectiveness in reducing the burden of caregivers.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Others

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Independence and care prevention benefits of the standing-assistive power wheelchair

Key secondary outcomes

Efficacy in Reducing Caregiver Burden
Comfortness and physical load reduction effect
Safety and ease of function acquisition


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Standing-assist power wheelchair use

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Muscular dystrophy patients receiving outpatient care or hospitalized at collaborating institutions
Patients who are able to learn to operate a standing-assisted electric wheelchair
Written consent of the research subject

Key exclusion criteria

Patients with intellectual disabilities and are challenged to operate a standing-assistive power wheelchair safely.
Patients are considered at high risk for a standing-assistive power wheelchair due to severe heart failure, fatal arrhythmia, spinal deformity, or contracture.
Patients who are presumed to be at high risk for a standing-assistive power wheelchair due to active diseases (e.g., pneumonia)
Patients whom the principal investigator or principal investigator determines are not appropriate to participate in this study.

Target sample size

15


Research contact person

Name of lead principal investigator

1st name Tsuyoshi
Middle name
Last name Matsumura

Organization

National Hospital Organization Osaka Toneyama National Hospital

Division name

Neurology

Zip code

560-8552

Address

Toneyama 5-1-1, Toyonaka, Osaka

TEL

06-6853-2001

Email

matsumura.tsuyoshi.kq@mail.hosp.go.jp


Public contact

Name of contact person

1st name Tsuyoshi
Middle name
Last name Matsumura

Organization

National Hospital Organization Osaka Toneyama National Hospital

Division name

Neurology

Zip code

560-8552

Address

Toneyama 5-1-1, Toyonaka, Osaka

TEL

06-6853-2001

Homepage URL


Email

matsumura.tsuyoshi.kq@mail.hosp.go.jp


Sponsor or person

Institute

National Hospital Organization Osaka Toneyama National Hospital

Institute

Department

Personal name



Funding Source

Organization

Ministry of Health, Labour and Welfare

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Hospital Organization Osaka Toneyama Medical Center

Address

Toneyama 5-1-1, Toyonaka, Osaka

Tel

06-6853-2001

Email

410-chiken@mail.hosp.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立病院機構新潟病院
国立病院機構鈴鹿病院
国立病院機構松本医療センター
国立病院機構沖縄病院
聖マリア病院
名古屋市立大学


Other administrative information

Date of disclosure of the study information

2022 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

11

Results

Most patients were satisfied with the variety of positioning. Since this survey was limited to in-hospital use, evaluating the effectiveness in social life and its efficacy in reducing caregivers' burden was difficult. Some respondents commented that the size and weight of the wheelchair made it difficult to use at home and that it took a particular time to get used to operating it. One person who mishandled the wheelchair suffered a broken toe, but this was not due to a defect in the wheelchair.

Results date posted

2023 Year 10 Month 01 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events

Toe fracture due to mishandling

Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 08 Month 15 Day

Date of IRB

2022 Year 09 Month 20 Day

Anticipated trial start date

2022 Year 10 Month 01 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry

2023 Year 04 Month 30 Day

Date trial data considered complete

2023 Year 05 Month 31 Day

Date analysis concluded

2024 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2022 Year 09 Month 28 Day

Last modified on

2023 Year 10 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055892


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name